Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-07-31

FDA Approved: SAXAGLIPTIN AND METFORMIN — Original Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved the original application for a generic fixed-dose combination of saxagliptin and metformin (SAXAGLIPTIN AND METFORMIN) from Mylan Pharmaceutica…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SAXAGLIPTIN AND METFORMIN (saxagliptin and metformin)

Snippet

ORIG AP for SAXAGLIPTIN AND METFORMIN (SAXAGLIPTIN AND METFORMIN)